- Home
- MLTX vs REX Comparison
MLTX vs REX Comparison
Compare MLTX & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | REX |
|---|---|---|
| Founded | 2021 | 1980 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MLTX | REX |
|---|---|---|
| Price | $17.84 | $39.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $25.70 | $25.00 |
| AVG Volume (30 Days) | ★ 1.1M | 132.5K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.18 |
| Revenue | N/A | ★ $642,491,000.00 |
| Revenue This Year | N/A | $3.27 |
| Revenue Next Year | N/A | $17.11 |
| P/E Ratio | ★ N/A | $32.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.95 | $30.02 |
| 52 Week High | $62.75 | $64.95 |
Technical Indicators
Market Signals| Indicator | MLTX | REX |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 77.68 |
| Support Level | $17.00 | $38.88 |
| Resistance Level | $19.15 | $43.62 |
| Average True Range (ATR) | 0.88 | 1.14 |
| MACD | -0.05 | 0.40 |
| Stochastic Oscillator | 37.35 | 98.88 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.